Immunic AG | WebDisclosure

Basculer en Français

8205	Companies
109437	Keywords
51603	Articles
60273	Press releases

Home
Companies
Immunic AG

BRIEF

published on 04/30/2024 at 12:35, 6 months 4 days ago

Immunic Highlights Extended Data from EMPhASIS Trial in Peer-Reviewed Journal

Vidofludimus Calcium EMPhASIS Trial Relapsing-remitting Multiple Sclerosis Neuroprotection Immune Modulation
PRESS RELEASE

published on 04/30/2024 at 12:30, 6 months 4 days ago

Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in RRMS in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation
Immunic announces publication of extended data from phase 2 EMPhASIS trial of Vidofludimus Calcium in RRMS in Neurology Neuroimmunology & Neuroinflammation journal

Immunic Vidofludimus Calcium EMPhASIS Trial Neurology Journal RRMS
BRIEF

published on 04/04/2024 at 12:35, 7 months ago

Immunic participera à la prochaine journée de recherche sur la SEP et aux conférences pour les investisseurs

Biotechnologie Vidofludimus Calcium Conférences Investisseurs Immunitaire Recherche Sur La SP
BRIEF

published on 04/04/2024 at 12:35, 7 months ago

Immunic to Participate in Upcoming MS Research Day and Investor Conferences

Biotechnology Investor Conferences Immunic Vidofludimus Calcium MS Research
PRESS RELEASE

published on 04/04/2024 at 12:30, 7 months ago

Immunic to Host MS R&D Day and Participate in Investor Conferences in April
Immunic, Inc. to host Multiple Sclerosis (MS) Research and Development (R&D) Day and participate in investor conferences in April, showcasing latest developments and clinical data

Investor Conferences Immunic Inc. Clinical Pipeline Multiple Sclerosis R&D Day
BRIEF

published on 03/20/2024 at 11:35, 7 months 15 days ago

Immunic obtient l'autorisation d'un brevet américain pour une nouvelle formulation de calcium Vidofludimus

Propriété Intellectuelle Vidofludimus Calcium Maladies Auto-immunes Immunitaire Brevet Polymère
BRIEF

published on 03/20/2024 at 11:35, 7 months 15 days ago

Immunic Secures U.S. Patent Allowance for Novel Vidofludimus Calcium Formulation

Intellectual Property Immunic Vidofludimus Calcium Autoimmune Diseases Polymer Patent
PRESS RELEASE

published on 03/20/2024 at 11:30, 7 months 15 days ago

Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
Immunic receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States, enhancing intellectual property protection

Patent Intellectual Property Immunic Vidofludimus Calcium Notice Of Allowance

Accesswire

Published on 11/05/2024 at 03:30, 1 hour 36 minutes ago

CORRECTION: Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/05/2024 at 00:00, 5 hours 6 minutes ago

Axcap Ventures Announces Upsizing of Private Placement
Published on 11/04/2024 at 23:00, 6 hours 6 minutes ago

Jericho Energy Ventures Announces Plan to Separate Hydrogen Platform from Traditional Energy Assets to Maximize Shareholder Value
Published on 11/04/2024 at 23:00, 6 hours 6 minutes ago

APEX/IFSA Global EXPO Showcases the Future of Aviation With Nearly 3,000 Industry ‎Professionals in Attendance
Published on 11/04/2024 at 22:45, 6 hours 21 minutes ago

Alphinat Announces a Profit of $160,597 for Fiscal Year Ended August 31, 2023

View all ACCESSWIRE

EQS Group

Published on 11/04/2024 at 22:20, 6 hours 45 minutes ago

Adler Group S.A. announces the sale of its 62.78% stake in Brack Capital Properties N.V. to LEG Immobilien SE
Published on 11/04/2024 at 21:15, 7 hours 50 minutes ago

EQS-Adhoc: LEG Immobilien SE: Acquisition of Brack Capital Properties N.V. through the conclusion of a share purchase agreement and a tender commitment in the event of a public offer
Published on 11/04/2024 at 19:00, 10 hours 5 minutes ago

EQS-Adhoc: Salzgitter Aktiengesellschaft: Potential voluntary public takeover bid to the shareholders of Salzgitter AG
Published on 11/04/2024 at 19:00, 10 hours 6 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 28 OCTOBRE 2024 au 01 NOVEMBRE 2024
Published on 11/04/2024 at 19:00, 10 hours 6 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF

Les Echos

Published on 11/04/2024 at 18:13, 10 hours 52 minutes ago

Thales : lancement de l’opération 2024 d’actionnariat salarié
Published on 11/04/2024 at 18:13, 10 hours 52 minutes ago

Thales: Launch of the 2024 Employee Share Ownership Plan
Published on 11/04/2024 at 18:11, 10 hours 54 minutes ago

Monthly disclosure of the total number of shares and voting rights - 31/10/2024
Published on 11/04/2024 at 18:11, 10 hours 54 minutes ago

Déclaration mensuelle des actions et droits de vote – 31/10/2024
Published on 11/04/2024 at 17:45, 11 hours 21 minutes ago

Disclosure of trading in own shares from October 29th, 2024, to November 1st, 2024. Detailed information per transaction.

View all LES ECHOS COMFI WIRE